Page 280 - Feline Cardiology
P. 280

Chapter 19: Congestive Heart Failure  287


              Pharmacodynamic effects of furosemide              and improved exercise abilities in dogs with CHF due to
              In the cat, acute diuresis occurs 5 minutes after intrave-  naturally  occurring  DCM  or  mitral  valve  disease
              nous injection of furosemide, with a peak diuretic effect   (Ettinger  et  al.  1998;  IMPROVE  Study  Group  1995;
              seen at 15 minutes (Friedman and Roch-Ramel 1977).   COVE Study Group 1995; BENCH Study Group 1999).
              In a study of normal anesthetized cats, urinary flow rate   Hemodynamic benefits in dogs with CHF include mild
              increased by 6, 15, and 18-fold after intravenous injec-  reductions in heart rate, mean arterial pressure, pulmo-
              tions of 0.2 mg/kg, 1 mg/kg, and 5 mg/kg of furosemide   nary artery pressure, and marginal reduction of pulmo-
              (Friedman  and  Roch-Ramel  1977).  Renal  blood  flow   nary capillary pressure (IMPROVE Study Group 1995).
              was increased up to 45% of control in a dose-dependent   There  is  only  one  prospective,  randomized,  blinded
              manner without altering glomerular filtration rate, indi-  multicenter study that has evaluated the effect of enala-
              cating  balanced  dilation  of  afferent  and  efferent  renal   pril compared to diltiazem or atenolol, on survival in
              arterioles  (Friedman  and  Roch-Ramel  1977).  The   symptomatic cats with congestive heart failure or arte-
              increase in renal blood flow is abolished by pretreatment   rial thromboembolism. 118 cats were enrolled, includ-
              with  inhibitors  of  prostaglandin  synthesis  including   ing 57 cats with HCM and 37 cats with HOCM. Although
              indomethacin (Kirschenbaum et al. 1974). Nonsteroidal   no  treatment  improved  survival,  there  was  a  trend
              anti-inflammatory drugs also lessen the diuretic response   toward  improved  survival  in  the  enalapril  group
              to furosemide by increasing solute reabsorption at the   (p = 0.06),  and  effects  may  have  been  underestimated
              thick ascending loop of Henle, and this potential con-  due to the low power of the study (∼30 cats/group) (Fox
              tributor to diuretic resistance, particularly in cats taking   2003). Early use of ACE inhibitors as monotherapy in
              aspirin or clopidogrel for anticoagulation, has not been   asymptomatic  cats  with  HCM  does  not  appear  to  be   Congestive Heart Failure
              investigated in this species (Chennavasin et al. 1980).  warranted, based on a placebo-controlled, blinded, ran-
                                                                 domized,  prospective  clinical  study  in  26  Maine  coon
              Adjunctive physiologic effects of furosemide       cats with familial HCM (MacDonald et al. 2006).
              Furosemide causes a dose-dependent direct venodilator   Drug properties of ACE inhibitors
              effect that occurs 5 minutes after intravenous injection,
              prior to onset of diuresis (Bayne and Williamson 1979).   The negatively charged group of the ACE inhibitor binds
              The venodilation appears to be mediated by a local vas-  to the zinc ions of ACE, preventing access by ACE sub-
              cular prostaglandin synthesis and local release of nitric   strates including angiotensin I and the vasodilator bra-
              oxide  (de  Berrazueta  et  al.  2007).  Acute  pulmonary   dykinin  (Zhu  et  al.  1997;  Brown  and  Vaughan  1998;
              venodilation decreases preload and lessens pulmonary   Wong  et  al.  2004).  By  inhibiting  the  action  of  ACE,
              edema accumulation. Furosemide also causes broncho-  angiotensin II formation is reduced and bradykinin (a
              dilation in horses and people, although no studies have   vasodilator) is increased. The potency and duration of
              evaluated this in dogs or cats (Niven 2003; Rubie et al.   an ACE inhibitor depends on its binding characteristics
              1993).  In  horses  with  recurrent  airway  obstruction,   rather than its tissue penetrating properties (Shu et al.
              1 mg/kg  furosemide  IV  reduced  pulmonary  resistance   1997; Zeitz et al. 2003). The majority of ACE inhibitors
              and increased lung compliance acutely within 15 minutes   are administered as a pro-drug (i.e., enalapril), which is
              after administration, which persisted for 5 hours. This   metabolized by the liver into the active drug (i.e., enala-
              effect  was  mediated  by  prostanoids  rather  than  by  a   prilat).  Most  ACE  inhibitors,  except  benazepril  and
              diuretic effect. Sometimes cats are incorrectly diagnosed   ramipril,  are  eliminated  entirely  by  the  kidneys,  and
              with congestive heart failure yet improve after furose-  reduction  of  dosage  is  necessary  in  the  face  of  renal
              mide  administration.  An  intriguing  postulate  is  that   dysfunction  (Vuong  and  Annis  2003).  Benazepril  is
              they improve due to furosemide induced bronchodila-  mainly metabolized by the liver (85%), and pharmaco-
              tion, but this has not been studied in cats.       kinetics are unaffected by renal dysfunction (King et al.
                                                                 2002).  Likewise,  87%  of  ramiprilat  was  eliminated  in
              Angiotensin Converting Enzyme                      the  feces  in  healthy  cats,  although  no  studies  have
              Inhibitors (ACEIs)                                 been  done  to  evaluate  whether  pharmacokinetics  are
              ACE inhibitors are the standard of care for treatment of   altered by renal dysfunction (Desmoulins et al. 2008).
              congestive  heart  failure  in  dogs  as  well  as  people,  but   Gastrointestinal  absorption  of  ACE  inhibitors  is  not
              studies are lacking in cats (Ettinger et al. 1998; IMPROVE   affected by presence of food. The clinical relevance of
              Study Group 1995; COVE Study Group 1995; BENCH     renal  versus  hepatic  elimination  of  ACE  inhibitors
              Study Group 1999). Several clinical trials have identified   applies to cats with acute oliguric or anuric renal failure,
              improved  survival,  clinical  reduction  in  heart  failure   who  may  be  unable  to  effectively  eliminate  renally
              class, fewer hospitalizations, reduced morbidity scores,   excreted ACE inhibitors. Cats with both congestive heart
   275   276   277   278   279   280   281   282   283   284   285